Dr. Nayak is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 Elmwood Ave 690
Rochester, NY 14642Phone+1 585-275-5944Fax+1 585-273-1104
Education & Training
- University of RochesterFellowship, Pediatric Infectious Diseases, 2007 - 2010
- University of RochesterResidency, Pediatrics, 2004 - 2007
- Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2004
Certifications & Licensure
- NY State Medical License 2007 - 2026
- AZ State Medical License 2020 - 2024
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Infectious Diseases
Clinical Trials
- Influenza Immunity in Children Start of enrollment: 2015 Oct 01
- Development of Childhood Anti-Influenza Immunity Start of enrollment: 2018 Sep 25
- Development of Childhood Anti-influenza Immunity Start of enrollment: 2018 Sep 25
Publications & Presentations
PubMed
- Development of Influenza-Specific CD4 T Cell-Mediated Immunity in Children Following Inactivated Influenza Vaccination.Ian Shannon, Nelson Huertas, Chantelle L White, Hongmei Yang, Jennifer L Nayak
Journal of the Pediatric Infectious Diseases Society. 2024-11-04 - 8 citationsThe Negative Effect of Preexisting Immunity on Influenza Vaccine Responses Transcends the Impact of Vaccine Formulation Type and Vaccination History.Savannah A Moritzky, Katherine A Richards, Maryah A Glover, Florian Krammer, Francisco A Chaves
The Journal of Infectious Diseases. 2023-02-01 - 54 citationsEvaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of Age.Evan J Anderson, C Buddy Creech, Vladimir Berthaud, Arin Piramzadian, Kimball A Johnson
The New England Journal of Medicine. 2022-11-03
Journal Articles
- CD4 T Cells in Protection from Influenza Virus: Viral Antigen Specificity and Functional PotentialJennifer Nayak, MD, Immunological Reviews
Press Mentions
- New mRNA Universal Flu Vaccine Against All Known Subtypes Takes Promising First StepsJanuary 15th, 2023
- What Australia’s Flu Season Could Mean for the US This WinterSeptember 22nd, 2022
- URMC Seeking Volunteers for Family COVID-19 StudySeptember 19th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: